Related Experiment Video

Updated: Apr 4, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.6K

STAT1 modification improves therapeutic effects of interferons on lung cancer cells

Junjie Chen1, Jialu Zhao2, Lefu Chen3

  • 1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China. jiestory414@163.com.

Journal of Translational Medicine
|September 10, 2015
PubMed
Abstract

Insights

Modified Signal Transducer and Activator of Transcription 1 (STAT1-CC) enhances interferon (IFN) anti-cancer effects in lung cancer cells. This STAT1-CC approach shows promise for future lung cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Interferons (IFNs) possess anti-cancer properties but face clinical limitations due to toxicity and poor pharmacokinetics, especially in solid tumors.
  • Achieving sustained therapeutic IFN levels in solid tumors remains a challenge for effective cancer treatment.

Purpose of the Study:

  • To investigate the potential of overexpressing Signal Transducer and Activator of Transcription 1 (STAT1) or a hyper-responsive variant (STAT1-CC) to enhance IFN efficacy in lung cancer.
  • To evaluate the impact of STAT1 and STAT1-CC on lung cancer cell proliferation, migration, invasiveness, and apoptosis.

Main Methods:

  • Overexpression of STAT1 or STAT1-CC in lung cancer cell lines (SPC-A-1, H1299) using lentiviral vectors.
  • Treatment with Interferon-gamma (IFN-γ) or Interferon-beta (IFN-β) and assessment of cellular responses (proliferation, migration, apoptosis).
  • Analysis of key protein and gene expression levels (STAT1, pSTAT1, fibronectin, β-catenin, S100A4, PCNA, c-fos) via Western blotting and other assays.

Main Results:

  • STAT1 and STAT1-CC expression significantly enhanced the inhibitory effects of IFNs on lung cancer cell proliferation, migration, and invasiveness.
  • STAT1/STAT1-CC overexpression led to increased STAT1 phosphorylation (pSTAT1) and reduced levels of fibronectin and β-catenin.
  • STAT1-CC demonstrated superior enhancement of IFN-γ-induced pSTAT1 and greater downregulation of S100A4, PCNA, and c-fos compared to STAT1.

Conclusions:

  • STAT1-CC significantly boosts the anti-tumor response of IFNs in lung cancer cells, outperforming STAT1.
  • Combined treatment with IFNs and STAT1-CC represents a promising therapeutic strategy for future clinical management of lung cancer.

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

15.4K

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K